AdvisorShares Psychedelics Valuation
| PSIL Etf | USD 16.69 0.42 2.45% |
At this time, the entity appears to be fairly valued. AdvisorShares Psychedelics shows a prevailing Real Value of $16.88 per share. The current price of the entity is $16.69. Our model approximates the value of AdvisorShares Psychedelics from analyzing the entity fundamentals such as net asset of 7.74 M, and Beta of 0.6 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that AdvisorShares Psychedelics' price fluctuation is not too volatile at this time. Calculation of the real value of AdvisorShares Psychedelics is based on 3 months time horizon. Increasing AdvisorShares Psychedelics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AdvisorShares etf is determined by what a typical buyer is willing to pay for full or partial control of AdvisorShares Psychedelics ETF. Since AdvisorShares Psychedelics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AdvisorShares Etf. However, AdvisorShares Psychedelics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.69 | Real 16.88 | Hype 17.11 | Naive 16.96 |
The intrinsic value of AdvisorShares Psychedelics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence AdvisorShares Psychedelics' stock price.
Estimating the potential upside or downside of AdvisorShares Psychedelics ETF helps investors to forecast how AdvisorShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AdvisorShares Psychedelics more accurately as focusing exclusively on AdvisorShares Psychedelics' fundamentals will not take into account other important factors: About AdvisorShares Psychedelics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of AdvisorShares Psychedelics ETF. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of AdvisorShares Psychedelics based exclusively on its fundamental and basic technical indicators. By analyzing AdvisorShares Psychedelics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of AdvisorShares Psychedelics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of AdvisorShares Psychedelics. We calculate exposure to AdvisorShares Psychedelics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AdvisorShares Psychedelics's related companies.The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in AdvisorShares Psychedelics ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
AdvisorShares Psychedelics's market price often diverges from its book value, the accounting figure shown on AdvisorShares's balance sheet. Smart investors calculate AdvisorShares Psychedelics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since AdvisorShares Psychedelics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between AdvisorShares Psychedelics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding AdvisorShares Psychedelics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.